Back

Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: a cross-sectional study

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Hypertension treatment: drugs and devices Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Enayet Karim Chowdhury

Curtin University, Perth (Australia)

14 More presentations in this session

Presentation thumbnail
Central-acting aminopeptidase a inhibitors for new treatment of hypertension: from discovery to clinical trial.
Doctor R. Hmazzou (Paris, FR)
Abstract
Presentation thumbnail
Efficacy and safety of valsartan in children aged 1-5 years with hypertension, with or without chronic kidney disease: A 6-week randomised, multicentre, double-blind study followed by open-label phase
Doctor K. Bapatla (Hyderabad, IN)
Abstract Slides
Presentation thumbnail
Thrombin generation and platelet function in patients on RAAS inhibitors
Doctor C. Helten (Duesseldorf, DE)
Abstract
Presentation thumbnail
Hemodynamic management of resistant hypertension
Doctor F. Chacon-Lozsan (Budapest, HU)
Abstract Slides
Presentation thumbnail
Assess of angiotensin receptor blockers therapy associated to mineralocorticoid receptor antagonists or to calcium channel blockers plus hydrochlorothiazide according central haemodynamic parameters
Doctor C. Paterno Marchioli (Castiglion Fiorentino (AR), IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Hypertension treatment: drugs and devices

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources